Application | Comment | Organism |
---|---|---|
medicine | trend toward lower drug response in patients with the NQO1 null genotype. Inhibiting NQO1 activity decreases p53 levels and drug induced apoptosis in chronic lymphocytic leukemia cells. NQO1 polymorphism may be a risk factor for chronic lymphocytic leukemia especially in males, and a predictor of response to chemotherapy | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
dicoumarol | - |
Homo sapiens | |
ES936 | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HCT-116 cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
NAD(P)H:quinoneoxidoreductase 1 | - |
Homo sapiens |
NQO1 | - |
Homo sapiens |